Bicara Therapeutics awards inducement grants under Nasdaq Rule 5635(c)(4)
Bicara Therapeutics said it awarded inducement grants on Sept. 1, 2026 to two new employees under Nasdaq Listing Rule 5635(c)(4).
BOSTON, Sept.
03, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc.
NASDAQ:BCAX, a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, today announced it awarded inducement grants on September 1, 2026 to two new employe…